Routes Pharmaceuticals Private Limited
About Routes Pharmaceuticals Private Limited
Data last updated:
Routes Pharmaceuticals Private Limited is a private limited company based in Bhopal, Madhya Pradesh, India. It operates in the manufacturing segment of the chemicals sector. It was incorporated on 09 May 2019 and has been in existence for over 7 years.
The company is registered with the Registrar of Companies (ROC), Gwalior, under CIN U24239MP2019PTC048568. Its GSTIN is 23AAJCR5901M1Z7 (Madhya Pradesh).
The company has an authorised share capital of ₹10 Lakh and a paid-up capital of ₹1.02 Lakh. It is led by directors Sudeepta Sinha and Arti Sharma.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Plot No. 90 First Floor Anoop Tower M.P. Nagar Zone – 2, Bhopal, Madhya Pradesh, India – 462011.
As per the financials filed for FY 2025, the company reported a revenue of ₹28.93 Lakh, a growth of 3% compared to the previous year. For the same year it recorded a net profit of ₹20,780 (net margin 0.7%) and EBITDA of ₹90,900 (EBITDA margin 3.1%). Revenue has grown at a compounded annual rate (CAGR) of 7% over three years and 96% over five years.
As per MCA filings, the company has open charges of ₹7 Lakh on record.
Company details
Contact details
Routes Pharmaceuticals Private Limited's registered office is in Bhopal, Madhya Pradesh. Its e-mail address is in the company report.
- Email
- Registered AddressPlot No. 90 First Floor Anoop Tower M.P. Nagar Zone – 2, Bhopal, Madhya Pradesh, India – 462011
- IndustryChemicals, Manufacturing, Other Chemical Product
To see the full contact details of Routes Pharmaceuticals Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Routes Pharmaceuticals is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products |
To see the full business activity and turnover split of Routes Pharmaceuticals Private Limited, buy the company report.
Financials of Routes Pharmaceuticals Private Limited
FY 2025 filings availableRoutes Pharmaceuticals Private Limited reported revenue of ₹28.93 Lakh (up 3% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR)
Revenue has grown at a compounded annual rate (CAGR) of 96% over five years, including 3% growth in the latest year. EBITDA rose 71% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹90,900 | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹20,780 | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 3.1% | ||||
| Net Profit Margin | 0.7% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Routes Pharmaceuticals Private Limited, buy the company report.
Board of directors of Routes Pharmaceuticals Private Limited
Routes Pharmaceuticals has 2 current directors and 2 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Sudeepta Sinha | Director | 09 May 2019 | 7 Years 5 Months | Current |
| Arti Sharma | Additional Director | 01 Dec 2022 | 3 Years 10 Months | Current |
Charges & borrowings
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 03 Oct 2024 | 100984830 | Canara Bank | ₹7 Lakh | Open |
Total charge records: 1 View all charges
Legal cases
No court or tribunal cases involving Routes Pharmaceuticals Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Routes Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Routes Pharmaceuticals has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 23AAJCR5901M1Z7 | Madhya Pradesh | Active | 30 Dec 2019 |
To see the full GST registrations and return filing status of Routes Pharmaceuticals Private Limited, buy the company report.
Recent activity
Routes Pharmaceuticals Private Limited has 4 board changes on record since 2019: 2 appointments and 2 cessations. The latest: Arti Sharma was appointed as Additional Director on 01 Dec 2022.
Frequently asked questions
Routes Pharmaceuticals is an active private limited company based in Bhopal, Madhya Pradesh, India. The company works in manufacturing, within the chemicals industry. It was incorporated on 09 May 2019 (7+ years old) and is registered under CIN U24239MP2019PTC048568.
Routes Pharmaceuticals has 2 current directors:
- Sudeepta Sinha - Director
- Arti Sharma - Additional Director
The latest financial statements of Routes Pharmaceuticals on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2020 are in the company report.
The GSTIN of Routes Pharmaceuticals is 23AAJCR5901M1Z7, registered in Madhya Pradesh.
The CIN (Corporate Identification Number) of Routes Pharmaceuticals is U24239MP2019PTC048568. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Routes Pharmaceuticals was incorporated on 09 May 2019, making it 7+ years old. It is registered with the Registrar of Companies, Gwalior.
Arti Sharma was appointed as Additional Director on 01 Dec 2022. Salil Badkur ceased to be Director on 14 Apr 2022. Vijendra Kumar Sharma ceased to be Director on 02 Dec 2019. Routes Pharmaceuticals has 4 board changes on record in total.
The registered office of Routes Pharmaceuticals is at Plot No. 90 First Floor Anoop Tower M.P. Nagar Zone – 2, Bhopal, Madhya Pradesh, India – 462011.
Routes Pharmaceuticals operates in the chemicals industry, in the manufacturing segment.
Routes Pharmaceuticals has open charges of ₹7 Lakh and no satisfied charges on record as per latest MCA filings.